ActHIB™

BIOLOGICAL3 trials

Sponsors

GlaxoSmithKline, Merck Sharp & Dohme LLC

Conditions

Bacterial InfectionsHaemophilus Influenzae Type bHepatitis AVirus Diseases

Phase 3

Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months

CompletedNCT00197236

GlaxoSmithKlineHepatitis A

Start: 2003-11-11End: 2007-12-03Updated: 2018-08-20

Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants

CompletedNCT01000974

GlaxoSmithKlineHaemophilus Influenzae Type b

Start: 2010-06-18End: 2013-07-17Updated: 2018-07-12

Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)

CompletedNCT01337167

Merck Sharp & Dohme LLCBacterial Infections, Virus Diseases

Start: 2011-04-19End: 2013-05-09Updated: 2018-11-15

Related Papers

Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.

2017-05-20

1112A Phase III Study of the Safety, Tolerability and Immunogenicity of an Investigational Combination Vaccine against Diphtheria, Tetanus, Pertussis (DTaP5), Polio (IPV), Haemophilus influenzae type b (Hib; PRP-OMPC), and Hepatitis B (HepB) in US Infants

Open Forum Infectious Diseases2014-01-01

Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.

2011-09-013 citations